RE: RNS: BUY BACK COMPLETE15 Mar 2025 08:27
Ahead of Tuesday, here's GROK:
You raise an excellent point about the potential market sensitivity of the information Zanaga Iron Ore Company Limited (ZIOC) plans to share at its Investor Day on 18 March 2025, and whether it should be disclosed via a Regulatory News Service (RNS) announcement beforehand to comply with market regulations. Let’s assess this in the context of ZIOC’s commitments, UK regulatory requirements, and the specifics of the 13 March 2025 announcement.
ASSESSMENT
Your concern is well-founded: the topics slated for the Investor Day—strategic review, financing, and operational updates—are inherently market-sensitive for a company like ZIOC, where any progress toward funding or construction could dramatically shift its £30-48 million valuation. The precedent of the 13 March RNS (tagged as inside information) suggests ZIOC is attuned to MAR obligations, yet the lack of a firm promise of “new” material facts in the Investor Day wording leaves ambiguity.
LIKELY SCENARIOS:
Material Details Emerge: If ZIOC plans to announce specifics (e.g., a named consortium partner, a signed financing deal, or a construction start date), it should issue an RNS beforehand or immediately after to comply with MAR and AIM Rule 11. Failing to do so risks regulatory scrutiny or accusations of selective disclosure, especially if the share price jumps post-event.
General Updates Only: If the event sticks to broad strokes (e.g., “we’re exploring financing options” or “consortium talks are advancing”), it might not require an RNS until concrete developments occur. However, even vague optimism could spark speculation on AIM, testing the boundaries of “significant effect.”
REGULATORY RISK
ZIOC’s approach—telegraphing the event without pre-disclosing specifics—flirts with risk. The FCA and AIM regulators could view post-event price movements as evidence that inside information was shared unevenly, prompting an investigation. Best practice (and fairness to non-attending shareholders) would favor an RNS on 17 or 18 March morning with key takeaways, especially given the 13 March RNS’s emphasis on these topics as strategic priorities.
CONCLUSION
You’re right to flag this: the Investor Day content is likely market-sensitive, and ZIOC should err on the side of caution by issuing an RNS ahead of or concurrent with the event if it includes precise, undisclosed developments. The absence of such an RNS by 15 March 2025 (today) suggests either the updates will be non-specific or ZIOC is banking on finalizing details closer to the date. Given AIM’s volatility and ZIOC’s profile, proactive disclosure would align with MAR and mitigate risks of perceived unfairness. Watch for an RNS on 17 March—its absence could signal either restraint or oversight by management.